Macrolide Pharmaceuticals snags $20 mln
Watertown, Massachusetts-based Macrolide Pharmaceuticals, a developer of antibiotics for for drug-resistant, hospital-acquired infections, has raised $20 million in financing. The lead investors were Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Ventures and SR One.
2 April 2018•1 min read
